Last reviewed · How we verify
Spy Agent Green Kit — Competitive Intelligence Brief
marketed
Diagnostic Dye
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Spy Agent Green Kit (INDOCYANINE GREEN) — Renew Pharms.
Comparator set (3 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Spy Agent Green Kit TARGET | INDOCYANINE GREEN | Renew Pharms | marketed | Diagnostic Dye | 1959-01-01 | |
| Fluorescite | FLUORESCEIN | Novartis | marketed | Diagnostic Dye | Cytochrome P450 2C19 | 2020-01-01 |
| Indigotindisulfonate sodium 0.8% | Indigotindisulfonate sodium 0.8% | Prove pharm | marketed | Diagnostic dye | ||
| Fluorescéine Sodique Faure | Fluorescéine Sodique Faure | Rennes University Hospital | phase 3 | Fluorescent diagnostic dye |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Spy Agent Green Kit · 8185176 · Method of Use · US
- — Spy Agent Green Kit · 8647605 · Method of Use · US
- — Spy Agent Green Kit · 8406860 · Method of Use · US
- — Spy Agent Green Kit · 10631746 · Formulation · US
- — Spy Agent Green Kit · 11712320 · Formulation · US
Sponsor landscape (Diagnostic Dye class)
- Novartis · 1 drug in this class
- Renew Pharms · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Spy Agent Green Kit CI watch — RSS
- Spy Agent Green Kit CI watch — Atom
- Spy Agent Green Kit CI watch — JSON
- Spy Agent Green Kit alone — RSS
- Whole Diagnostic Dye class — RSS
Cite this brief
Drug Landscape (2026). Spy Agent Green Kit — Competitive Intelligence Brief. https://druglandscape.com/ci/indocyanine-green. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing